RG
Richard S Geary
EVP, Chief Development Officer

Richard S Geary insider trades: Ionis Pharmaceuticals (IONS) stock sales

EVP, Chief Development Officer, Ionis Pharmaceuticals Last trade Nov 6, 2025 96 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
54
Open-market trades
since 2009
2
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

54 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 6, 2025IONS↓ Sell10b5-1$2.6M
Nov 3, 2025IONS↓ Sell10b5-1$6.8M
Sep 30, 2025IONS↓ Sell10b5-1$3.8M
Sep 2, 2025IONS↓ Sell10b5-1$504K
Aug 5, 2025IONS↓ Sell10b5-1$429K
Jan 31, 2025IONS↓ Sell$46K
Jan 16, 2025IONS↓ Sell$232K
Aug 29, 2024IONS↓ Sell10b5-1$32K
Aug 5, 2024IONS↓ Sell10b5-1$117K
Feb 2, 2024IONS↓ Sell$98K
Jan 17, 2024IONS↓ Sell$370K
Dec 21, 2023IONS↓ Sell$525K
Dec 14, 2023IONS↓ Sell$526K
Feb 6, 2023IONS↓ Sell$78K
Jan 18, 2023IONS↓ Sell$312K
Jan 13, 2021IONS↓ Sell10b5-1$8K
Nov 25, 2020IONS↓ Sell10b5-1$597K
Nov 24, 2020IONS↓ Sell10b5-1$657K
Dec 4, 2019IONS↓ Sell10b5-1$650K
Dec 2, 2019IONS↓ Sell10b5-1$325K
Apr 8, 2019IONS↓ Sell10b5-1$3.9M
Feb 13, 2019IONS↓ Sell10b5-1$60K
Jan 16, 2018IONS↓ Sell$141K
Oct 13, 2017IONS↓ Sell10b5-1$496K
Jan 17, 2017IONS↓ Sell$113K
Jan 19, 2016IONS↓ Sell$90K
Mar 19, 2015ISIS↓ Sell10b5-1$600K
Mar 5, 2015ISIS↓ Sell10b5-1$1.3M
Jan 16, 2015ISIS↓ Sell$105K
Jan 12, 2015ISIS↓ Sell10b5-1$44K
Jul 2, 2014ISIS↓ Sell10b5-1$6K
Jan 22, 2014ISIS↓ Sell10b5-1$1.1M
Jan 16, 2014ISIS↓ Sell$39K
Jan 8, 2014ISIS↓ Sell10b5-1$607K
Jul 11, 2013ISIS↓ Sell10b5-1$287K
Jul 9, 2013ISIS↓ Sell10b5-1$2.0M
Jul 3, 2013ISIS↓ Sell10b5-1$145K
Jun 25, 2013ISIS↓ Sell10b5-1$1.2M
Apr 19, 2013ISIS↓ Sell10b5-1$42K
Apr 11, 2013ISIS↓ Sell10b5-1$137K
Mar 21, 2013ISIS↓ Sell10b5-1$20K
Jan 16, 2013ISIS↓ Sell$5K
Jan 3, 2013ISIS↓ Sell10b5-1$3K
Dec 13, 2012ISIS↓ Sell10b5-1$58K
Jul 9, 2012ISIS↓ Sell10b5-1$77K
Jul 3, 2012ISIS↓ Sell10b5-1$31K
Jun 14, 2012ISIS↓ Sell10b5-1$17K
Dec 21, 2011ISIS↓ Sell10b5-1$8K
Dec 20, 2011ISIS↓ Sell10b5-1$27K
Dec 29, 2010ISIS↓ Sell10b5-1$55K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IONS insiders

Open-market trades in the last 12 months

About Richard S Geary's insider trades

Richard S Geary is EVP, Chief Development Officer at Ionis Pharmaceuticals (IONS). Since Jan 2, 2009, Richard has reported no open-market purchases and 54 sales worth $31.5M on SEC Form 4. There have been no open-market trades in the last 12 months.

40 sales (91% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (42 filings), grants and awards (34 filings), other transactions (32 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IONS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.